Sanofi India Limited

BSE: 500674 NSE: SANOFI
Sanofi India Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN L24239MH1956PLC009794 Incorporated 02 May 1956 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Listed - NSE: SANOFI · BSE: 500674 Public Limited Company pharma
Data last updated
Revenue · FY 2024
₹2,013.2 Cr
▼ 29.39% YoY
Computed EBITDA · FY 2024
₹507.3 Cr
▼ 41.62% YoY
Net profit · FY 2024
₹413.3 Cr
▼ 31.45% YoY
Authorised capital
₹23.5 Cr
Registered with MCA
Paid-up capital
₹23.03 Cr
Issued & subscribed
Open charges
₹170.72 Cr
Satisfied ₹40.81 Cr
Company age
70 yrs
Est. 1956
Employees · EPFO
2,191
Latest available

About Sanofi India Limited

Data last updated: 14 July 2026

Sanofi India Limited is a public limited company based in Mumbai, Maharashtra, India, a subsidiary of Hoechst Gmbh (Holding Company). It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 02 May 1956, the company has been in operation for over 70 years.

Registered with ROC Mumbai under CIN L24239MH1956PLC009794. Listed on BSE: 500674 and NSE: SANOFI.

Capital: an authorised share capital of ₹23.5 Cr and a paid-up capital of ₹23.03 Cr. Formerly known as Hoechst Fedco Pharma P Ltd and Hoechst Fedco Pharma Ltd. It is led by directors including Vaibhav Vinayak Karandikar and Rahul Bhatnagar.

Last AGM: 29 April 2026. Financial statements filed for year ended 31 December 2025. Office: Sanofi House Cts No.117 – B L&T Business Park Saki Vihar Road Powai, Mumbai, Maharashtra, India – 400072.

As per NSE-filed consolidated financials for FY 2024, the company reported a revenue of ₹2,013.2 Cr, a decline of 29.39% compared to the previous year. The net worth stands at ₹860.6 Cr (down 15.23% YoY). Total assets are valued at ₹1,611.8 Cr (down 6.01% YoY).

The company has a workforce of approximately 2,191 employees as per the latest available data. It operates as a subsidiary of Hoechst Gmbh (Holding Company). Its group structure includes 1 subsidiary.

The company is associated with 2 brands - Allergy Free, Sanofi India. As per MCA filings, the company has open charges of ₹170.72 Cr and satisfied charges of ₹40.81 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanofiindialtd.com.

Company Details of Sanofi India Limited
CIN L24239MH1956PLC009794
Registration Number 009794
Incorporation Date 02 May 1956
ROC Mumbai
Listing Status Listed (BSE: 500674, NSE: SANOFI)
Company Status Active
Date of Last AGM 29 April 2026
Date of Balance Sheet 31 December 2025
Parent Company Hoechst Gmbh (Holding Company)
Compliance Status Active Compliant
Key People
Deepak Arora Managing Director Mahadev Keshav Gawade Whole-Time Director Rachid Ayari Whole-Time Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    sanofiindialtd.com
  • Social Media
  • Registered Address
    Sanofi House Cts No.117 – B L&T Business Park Saki Vihar Road Powai, Mumbai, Maharashtra, India – 400072
  • Industry
    Pharma, Drug Formulation & Development
Company report
Sanofi India Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Sanofi India Limited report

Financials, compliance, directors, charges, ownership and filings for Sanofi India Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Sanofi India Limited

Sanofi India Limited has undergone 4 name changes throughout its history. The current legal name is Sanofi India Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Sanofi India Limited Current
Hoechst Fedco Pharma P Ltd Previous
Hoechst Fedco Pharma Ltd Previous
Aventis Pharma Limited Previous
Hoechst- Fedco Pharma Private Limited Previous

Associated Brands with Sanofi India Limited

Sanofi India Limited operates two associated brands: Allergy Free and Sanofi India. These brands represent Sanofi India Limited's diversified market presence and brand portfolio.

Brand Description Website
Allergy Free
Allergy education and management services in healthcare by Sanofi. allergyfree.co.in
Sanofi India
Manufacturer of pharmaceutical products and vaccines sanofiindialtd.com

Business Activity of Sanofi India Limited

Sanofi India Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
Locked Manufacturing Locked Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Detailed business activity records for Sanofi India Limited

Activity codes and turnover contribution percentages require an active report plan.

  • Activity group codes
  • Detailed activity codes
  • Turnover contribution

Verified entity values are shown only after access is granted.

Auditor Details of Sanofi India Limited

Sanofi India Limited is audited by Price Waterhouse & Co Chartered Accountants LLP for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
Price Waterhouse & Co Chartered Accountants LLP Locked Locked Locked
Premium access

Complete auditor history for Sanofi India Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Sanofi India Limited

Sanofi India Limited is currently managed by 9 directors, with 44 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Vaibhav Vinayak Karandikar Director 23 Feb 2021 5 Years 6 Months Current
Rahul Bhatnagar
Also directs: Rossell India Limited, Tasty Bite Eatables Ltd, Whirlpool Of India Limited and 1 more
Director 29 Jul 2020 6 Years 0 Months Current
Deepak Arora Managing Director 27 Oct 2025 0 Years 9 Months Current
Mahadev Keshav Gawade Whole-Time Director 11 Aug 2025 1 Years 0 Months Current
Eric Yves Mansion Director 03 Jun 2024 2 Years 2 Months Current
Rachid Ayari
Also directs: Apollo Sugar Clinics Limited
Whole-Time Director 01 Dec 2023 2 Years 8 Months Current
Showing 6 of 9 current directors. View all directors

Financials of Sanofi India Limited FY 2024 filings available

Sanofi India Limited reported revenue of ₹2,013.2 Cr (down 29.39% YoY) for FY 2024.

Revenue · FY 2024
₹2,013.2 Cr ▼ 29.39%
Profit · FY 2024
₹413.3 Cr ▼ 31.45%
Computed EBITDA · FY 2024
₹507.3 Cr ▼ 41.62%
Revenue₹ Cr · Consolidated01,0002,0003,000FY 2023: ₹2,851 Cr2,851FY 2023FY 2024: ₹2,013 Cr · -29.4% YoY2,013-29.4%FY 2024
Net Profit₹ Cr · Consolidated0250500750FY 2023: ₹603 Cr603FY 2023FY 2024: ₹413 Cr · -31.4% YoY413-31.4%FY 2024
Quarterly Revenue₹ Cr · vs same quarter last year0250500750Q1'24: ₹706 Cr706Q1'24Q2'24: ₹715 Cr715Q2'24Q3'24: ₹694 Cr694Q3'24Q4'24: ₹732 Cr732Q4'24Q1'25: ₹464 Cr · -34.4% YoY464-34.4%Q1'25Q2'25: ₹524 Cr · -26.7% YoY524-26.7%Q2'25Q3'25: ₹515 Cr · -25.8% YoY515-25.8%Q3'25
Metrics FY 2024 FY 2023
Revenue from Operations ₹2,013.2 Cr ₹2,851.1 Cr
Other Income ₹16.5 Cr ₹65.3 Cr
Total Income ₹2,029.7 Cr ₹2,916.4 Cr
Cost of Materials Consumed ₹354.8 Cr ₹564.4 Cr
Purchases of Stock-in-Trade ₹564.3 Cr ₹929 Cr
Changes in Inventories ₹60.2 Cr -₹292.4 Cr
Employee Benefit Expense ₹240.2 Cr ₹370.6 Cr
Finance Costs ₹1.5 Cr ₹1.7 Cr
Depreciation & Amortisation ₹36.7 Cr ₹39.6 Cr
Other Expenses ₹302.9 Cr ₹475.8 Cr
Total Expenses ₹1,560.6 Cr ₹2,088.7 Cr
Profit Before Exceptional Items & Tax ₹469.1 Cr ₹827.7 Cr
Exceptional Items -₹37.7 Cr ₹17.8 Cr
Profit Before Tax ₹431.4 Cr ₹845.5 Cr
Total Tax Expense ₹117.7 Cr ₹242.6 Cr
Net Profit ₹413.3 Cr ₹602.9 Cr
Other Comprehensive Income ₹7.2 Cr -₹1.3 Cr
Total Comprehensive Income ₹420.5 Cr ₹601.6 Cr
EBITDA (computed) ₹507.3 Cr ₹869 Cr
Basic EPS ₹136.21 ₹261.78
Diluted EPS ₹136.21 ₹261.78
Metrics FY 2024 FY 2023
Total Assets ₹1,611.8 Cr ₹1,714.8 Cr
Non-current Assets ₹347.5 Cr ₹466.8 Cr
Current Assets ₹1,264.3 Cr ₹1,248 Cr
Property, Plant & Equipment ₹255.8 Cr ₹310 Cr
Inventories ₹499.8 Cr ₹663.8 Cr
Trade Receivables ₹230 Cr ₹131.7 Cr
Cash & Equivalents ₹283.8 Cr ₹394.5 Cr
Equity (Net Worth) ₹860.6 Cr ₹1,015.2 Cr
Equity Share Capital ₹23 Cr ₹23 Cr
Borrowings (Non-current) ₹0 ₹0
Borrowings (Current) ₹0 ₹0
Total Debt (computed) ₹0 ₹0
Current Liabilities ₹719.2 Cr ₹651.3 Cr
Total Liabilities ₹751.2 Cr ₹699.6 Cr
Metrics FY 2024 FY 2023
Operating Cash Flow ₹461.5 Cr ₹230.4 Cr
Investing Cash Flow -₹19.2 Cr ₹37.5 Cr
Financing Cash Flow -₹553 Cr -₹878.3 Cr
Capital Expenditure ₹36.4 Cr ₹34.3 Cr
Free Cash Flow (computed) ₹425.1 Cr ₹196.1 Cr
Dividends Paid ₹384.6 Cr ₹868.3 Cr
Net Change in Cash -₹110.7 Cr -₹610.4 Cr
Metrics Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹514.9 Cr ₹524 Cr ₹463.5 Cr ₹732.4 Cr ₹693.9 Cr ₹714.58 Cr ₹706.1 Cr
Other Income ₹5.9 Cr ₹2.3 Cr ₹4.8 Cr ₹6.5 Cr ₹12 Cr ₹11.82 Cr ₹15.7 Cr
Total Income ₹520.8 Cr ₹526.3 Cr ₹468.3 Cr ₹738.9 Cr ₹705.9 Cr ₹726.4 Cr ₹721.8 Cr
Cost of Materials Consumed ₹102.7 Cr ₹93.1 Cr ₹82.1 Cr ₹143.7 Cr ₹133.5 Cr ₹130.99 Cr ₹154.4 Cr
Purchases of Stock-in-Trade ₹238.5 Cr ₹201.8 Cr ₹92.5 Cr ₹40.8 Cr ₹134.6 Cr ₹395.22 Cr ₹188.5 Cr
Changes in Inventories -₹91.4 Cr -₹34.93 Cr ₹46.5 Cr ₹123.9 Cr ₹12.2 Cr -₹226.43 Cr -₹26.6 Cr
Employee Benefit Expense ₹53.8 Cr ₹56.7 Cr ₹60.2 Cr ₹92.4 Cr ₹91.9 Cr ₹93.13 Cr ₹93.7 Cr
Finance Costs ₹40 Lakh ₹40 Lakh ₹40 Lakh ₹30 Lakh ₹40 Lakh ₹32.08 Lakh ₹70 Lakh
Depreciation & Amortisation ₹9.6 Cr ₹9 Cr ₹9 Cr ₹10 Cr ₹10.2 Cr ₹9.88 Cr ₹9.8 Cr
Other Expenses ₹93 Cr ₹87.64 Cr ₹66.5 Cr ₹112.7 Cr ₹134.3 Cr ₹113.41 Cr ₹117.9 Cr
Total Expenses ₹406.6 Cr ₹413.71 Cr ₹357.2 Cr ₹523.8 Cr ₹517.1 Cr ₹516.52 Cr ₹538.4 Cr
Profit Before Exceptional Items & Tax ₹114.2 Cr ₹112.59 Cr ₹111.1 Cr ₹215.1 Cr ₹188.8 Cr ₹209.88 Cr ₹183.4 Cr
Exceptional Items ₹8 Cr ₹0 -₹19 Cr -₹26.7 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹122.2 Cr ₹112.59 Cr ₹92.1 Cr ₹188.4 Cr ₹188.8 Cr ₹209.88 Cr ₹183.4 Cr
Total Tax Expense ₹30.9 Cr ₹30.4 Cr ₹23.9 Cr ₹51.8 Cr ₹51.1 Cr ₹57.93 Cr ₹60.5 Cr
Net Profit ₹91.3 Cr ₹82.19 Cr ₹103.2 Cr ₹136.6 Cr ₹137.7 Cr ₹151.95 Cr ₹122.9 Cr
  attributable to Owners - - - ₹0 - ₹0 ₹0
  attributable to NCI - - - ₹0 - ₹0 ₹0
Other Comprehensive Income ₹7.2 Cr ₹0 ₹0 ₹0 -₹1.3 Cr ₹0 ₹0
Total Comprehensive Income ₹98.5 Cr ₹82.19 Cr ₹103.2 Cr ₹136.6 Cr ₹136.4 Cr ₹151.95 Cr ₹122.9 Cr
EBITDA (computed) ₹124.2 Cr ₹121.99 Cr ₹120.5 Cr ₹225.4 Cr ₹199.4 Cr ₹220.08 Cr ₹193.9 Cr
Basic EPS ₹39.64 ₹35.69 ₹29.62 ₹59.31 ₹59.79 ₹65.95 ₹53.37
Diluted EPS ₹39.60 ₹35.69 ₹29.62 ₹59.31 ₹59.79 ₹65.95 ₹53.37
Latest 7 quarters shown.
Metrics FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Revenue from Operations ₹2,013.2 Cr ₹2,851.1 Cr ₹2,770.1 Cr ₹2,956.6 Cr ₹2,901.9 Cr
Other Income ₹16.5 Cr ₹65.3 Cr ₹71.5 Cr ₹74.4 Cr ₹89.8 Cr
Total Income ₹2,029.7 Cr ₹2,916.4 Cr ₹2,841.6 Cr ₹3,031 Cr ₹2,991.7 Cr
Cost of Materials Consumed ₹354.8 Cr ₹564.4 Cr ₹549.7 Cr ₹555.1 Cr ₹591.4 Cr
Purchases of Stock-in-Trade ₹564.3 Cr ₹929 Cr ₹651 Cr ₹708.6 Cr ₹604.7 Cr
Changes in Inventories ₹60.2 Cr -₹292.4 Cr -₹11.1 Cr ₹43.1 Cr ₹57.5 Cr
Employee Benefit Expense ₹240.2 Cr ₹370.6 Cr ₹405.9 Cr ₹433.9 Cr ₹460.8 Cr
Finance Costs ₹1.5 Cr ₹1.7 Cr ₹1.7 Cr ₹1.8 Cr ₹1.8 Cr
Depreciation & Amortisation ₹36.7 Cr ₹39.6 Cr ₹41.9 Cr ₹66.7 Cr ₹82.2 Cr
Other Expenses ₹302.9 Cr ₹475.5 Cr ₹470.2 Cr ₹453.4 Cr ₹474.4 Cr
Total Expenses ₹1,560.6 Cr ₹2,088.4 Cr ₹2,109.3 Cr ₹2,262.6 Cr ₹2,272.8 Cr
Profit Before Exceptional Items & Tax ₹469.1 Cr ₹828 Cr ₹732.3 Cr ₹768.4 Cr ₹718.9 Cr
Exceptional Items -₹37.7 Cr ₹17.8 Cr ₹132 Cr ₹489.2 Cr -₹41.7 Cr
Profit Before Tax ₹431.4 Cr ₹845.8 Cr ₹864.3 Cr ₹1,257.6 Cr ₹677.2 Cr
Total Tax Expense ₹117.7 Cr ₹242.6 Cr ₹243.7 Cr ₹313.2 Cr ₹199.6 Cr
Net Profit ₹413.5 Cr ₹603.2 Cr ₹620.6 Cr ₹944.4 Cr ₹477.6 Cr
Other Comprehensive Income ₹7.2 Cr -₹1.3 Cr ₹50 Lakh -₹3.3 Cr -₹8.8 Cr
Total Comprehensive Income ₹420.7 Cr ₹601.9 Cr ₹621.1 Cr ₹941.1 Cr ₹468.8 Cr
EBITDA (computed) ₹507.3 Cr ₹869.3 Cr ₹775.9 Cr ₹836.9 Cr ₹802.9 Cr
Basic EPS ₹136.00 ₹261.91 ₹269.47 ₹410.06 ₹207.38
Diluted EPS ₹136.00 ₹261.91 ₹269.47 ₹410.06 ₹207.38
Metrics FY 2024 FY 2023 FY 2022
Total Assets ₹1,611.8 Cr ₹1,715.1 Cr ₹2,071.7 Cr
Non-current Assets ₹347.6 Cr ₹468.8 Cr ₹461.4 Cr
Current Assets ₹1,264.2 Cr ₹1,246.3 Cr ₹1,609.3 Cr
Property, Plant & Equipment ₹311.3 Cr ₹310 Cr ₹305.2 Cr
Inventories ₹499.8 Cr ₹663.8 Cr ₹408 Cr
Trade Receivables ₹230 Cr ₹131.7 Cr ₹129.1 Cr
Cash & Equivalents ₹283.8 Cr ₹392.9 Cr ₹1,004.9 Cr
Equity (Net Worth) ₹860.6 Cr ₹1,015.5 Cr ₹1,275.8 Cr
Equity Share Capital ₹23 Cr ₹23 Cr ₹23 Cr
Borrowings (Non-current) ₹0 ₹0 ₹0
Borrowings (Current) ₹0 ₹0 ₹0
Total Debt (computed) ₹0 ₹0 ₹0
Current Liabilities ₹719.2 Cr ₹651.3 Cr ₹739.7 Cr
Total Liabilities ₹751.2 Cr ₹699.6 Cr ₹795.9 Cr
The balance sheet became part of the exchange results-filing format in FY2023 - earlier years were not filed and are hidden.
Metrics FY 2024 FY 2023 FY 2022 FY 2021
Operating Cash Flow ₹461.7 Cr ₹230.8 Cr ₹398.7 Cr ₹558.8 Cr
Investing Cash Flow -₹19.2 Cr ₹35.5 Cr ₹650.9 Cr ₹630.8 Cr
Financing Cash Flow -₹551.6 Cr -₹878.3 Cr -₹1,582.7 Cr -₹849 Cr
Capital Expenditure ₹36.4 Cr ₹34.3 Cr ₹22.2 Cr ₹23 Cr
Free Cash Flow (computed) ₹425.3 Cr ₹196.5 Cr ₹376.5 Cr ₹535.8 Cr
Dividends Paid ₹384.6 Cr ₹868.3 Cr ₹1,573 Cr ₹840.6 Cr
Net Change in Cash -₹109.1 Cr -₹612 Cr -₹533.1 Cr ₹340.6 Cr
The cash-flow statement became part of the exchange results-filing format in FY2022 - earlier years were not filed and are hidden.
Metrics Q4 FY26 Q3 FY26 Q2 FY26 Q1 FY26 Q4 FY25 Q3 FY25 Q2 FY25 Q1 FY25 Q4 FY24 Q3 FY24 Q2 FY24 Q1 FY24
Revenue from Operations ₹472.3 Cr ₹419.8 Cr ₹475.4 Cr ₹406.3 Cr ₹535.9 Cr ₹514.9 Cr ₹524 Cr ₹463.5 Cr ₹732.4 Cr ₹693.9 Cr ₹714.58 Cr ₹706.1 Cr
Other Income ₹4.4 Cr ₹2.8 Cr ₹4.9 Cr ₹8.7 Cr ₹3.3 Cr ₹5.9 Cr ₹2.3 Cr ₹4.8 Cr ₹6.5 Cr ₹12 Cr ₹11.82 Cr ₹15.7 Cr
Total Income ₹476.7 Cr ₹422.6 Cr ₹480.3 Cr ₹415 Cr ₹539.2 Cr ₹520.8 Cr ₹526.3 Cr ₹468.3 Cr ₹738.9 Cr ₹705.9 Cr ₹726.4 Cr ₹721.8 Cr
Cost of Materials Consumed ₹50.3 Cr ₹55.3 Cr ₹53.3 Cr ₹62.1 Cr ₹75.7 Cr ₹102.7 Cr ₹93.1 Cr ₹82.1 Cr ₹143.7 Cr ₹133.5 Cr ₹130.99 Cr ₹154.4 Cr
Purchases of Stock-in-Trade ₹148.2 Cr ₹124.5 Cr ₹269.8 Cr ₹35.6 Cr ₹84.1 Cr ₹238.5 Cr ₹201.8 Cr ₹92.5 Cr ₹40.8 Cr ₹134.6 Cr ₹395.22 Cr ₹188.5 Cr
Changes in Inventories ₹35.8 Cr ₹28.3 Cr -₹83.2 Cr ₹111 Cr ₹80.7 Cr -₹91.4 Cr -₹34.93 Cr ₹46.5 Cr ₹123.9 Cr ₹12.2 Cr -₹226.43 Cr -₹26.6 Cr
Employee Benefit Expense ₹42.8 Cr ₹44.7 Cr ₹41.9 Cr ₹44.9 Cr ₹53.8 Cr ₹53.8 Cr ₹56.7 Cr ₹60.2 Cr ₹92.4 Cr ₹91.9 Cr ₹93.23 Cr ₹93.7 Cr
Finance Costs ₹30 Lakh ₹60 Lakh ₹40 Lakh ₹40 Lakh ₹30 Lakh ₹40 Lakh ₹40 Lakh ₹40 Lakh ₹30 Lakh ₹40 Lakh ₹32.08 Lakh ₹70 Lakh
Depreciation & Amortisation ₹9 Cr ₹9.5 Cr ₹9.1 Cr ₹9.1 Cr ₹9.6 Cr ₹9.6 Cr ₹9 Cr ₹9 Cr ₹10 Cr ₹10.2 Cr ₹9.88 Cr ₹9.8 Cr
Other Expenses ₹52.4 Cr ₹76.7 Cr ₹59.4 Cr ₹57.8 Cr ₹69.7 Cr ₹93 Cr ₹87.64 Cr ₹66.5 Cr ₹112.7 Cr ₹134.3 Cr ₹113.12 Cr ₹117.9 Cr
Total Expenses ₹338.8 Cr ₹339.6 Cr ₹350.7 Cr ₹320.9 Cr ₹373.9 Cr ₹406.6 Cr ₹413.71 Cr ₹357.2 Cr ₹523.8 Cr ₹517.1 Cr ₹516.33 Cr ₹538.4 Cr
Profit Before Exceptional Items & Tax ₹137.9 Cr ₹83 Cr ₹129.6 Cr ₹94.1 Cr ₹165.3 Cr ₹114.2 Cr ₹112.59 Cr ₹111.1 Cr ₹215.1 Cr ₹188.8 Cr ₹210.07 Cr ₹183.4 Cr
Exceptional Items ₹0 ₹0 -₹27.3 Cr ₹0 ₹0 ₹8 Cr ₹0 -₹19 Cr -₹26.7 Cr ₹0 ₹0 ₹0
Profit Before Tax ₹137.9 Cr ₹83 Cr ₹102.3 Cr ₹94.1 Cr ₹165.3 Cr ₹122.2 Cr ₹112.59 Cr ₹92.1 Cr ₹188.4 Cr ₹188.8 Cr ₹210.07 Cr ₹183.4 Cr
Total Tax Expense ₹35.3 Cr ₹21.3 Cr ₹26.3 Cr ₹24.6 Cr ₹45.8 Cr ₹30.9 Cr ₹30.4 Cr ₹23.9 Cr ₹51.8 Cr ₹51.1 Cr ₹57.93 Cr ₹60.5 Cr
Net Profit ₹102.6 Cr ₹61.7 Cr ₹76 Cr ₹69.5 Cr ₹119.5 Cr ₹91.3 Cr ₹82.19 Cr ₹103.4 Cr ₹136.6 Cr ₹137.7 Cr ₹152.14 Cr ₹122.9 Cr
Other Comprehensive Income ₹0 ₹1.7 Cr ₹0 ₹0 ₹0 ₹7.2 Cr ₹0 ₹0 ₹0 -₹1.3 Cr ₹0 ₹0
Total Comprehensive Income ₹102.6 Cr ₹63.4 Cr ₹76 Cr ₹69.5 Cr ₹119.5 Cr ₹98.5 Cr ₹82.19 Cr ₹103.4 Cr ₹136.6 Cr ₹136.4 Cr ₹152.14 Cr ₹122.9 Cr
EBITDA (computed) ₹147.2 Cr ₹93.1 Cr ₹139.1 Cr ₹103.6 Cr ₹175.2 Cr ₹124.2 Cr ₹121.99 Cr ₹120.5 Cr ₹225.4 Cr ₹199.4 Cr ₹220.27 Cr ₹193.9 Cr
Basic EPS ₹44.55 ₹26.79 ₹32.99 ₹30.18 ₹51.89 ₹40.00 ₹35.69 ₹29.62 ₹59.31 ₹59.79 ₹66.08 ₹53.37
Diluted EPS ₹44.55 ₹26.79 ₹32.99 ₹30.18 ₹51.89 ₹40.00 ₹35.69 ₹29.62 ₹59.31 ₹59.79 ₹66.08 ₹53.37
Latest 12 quarters shown of 25 on record.
Want more history and ratios?
You're viewing the latest exchange-filed financials for Sanofi India Limited. The full report adds 10+ years of line-item history, 20+ ratios, peer benchmarks and a downloadable PDF.
10+ years of history 20+ ratios & benchmarks Downloadable PDF

Shareholding Pattern of Sanofi India Limited

As per the shareholding pattern filed with NSE for the quarter ended Mar 2026, promoters hold 60.40%, foreign institutional investors hold 5.64%, domestic institutional investors hold 21.13%, retail and other public shareholders hold 12.83% of Sanofi India Limited. The company had 75,758 shareholders on record.

Promoters: 60.40%DII (Domestic Institutional): 21.13%FII (Foreign Institutional): 5.64%Retail & Others: 12.83%
Mar 2026
QUARTER
60.40% Promoters
21.13% DII (Domestic Institutional)
5.64% FII (Foreign Institutional)
12.83% Retail & Others
Promoter holding - history
Now 60.40% · Mar 2026High 60.40% · Dec 2015Low 60.40% · Dec 2015
59%59.8%60.5%61.3%62%Dec 2015Jun 2018Dec 2020Jun 2023Dec 2025Dec 2015: 60.40%Mar 2016: 60.40%Jun 2016: 60.40%Sep 2016: 60.40%Dec 2016: 60.40%Mar 2017: 60.40%Jun 2017: 60.40%Sep 2017: 60.40%Dec 2017: 60.40%Mar 2018: 60.40%Jun 2018: 60.40%Sep 2018: 60.40%Dec 2018: 60.40%Mar 2019: 60.40%Jun 2019: 60.40%Sep 2019: 60.40%Dec 2019: 60.40%Mar 2020: 60.40%Jun 2020: 60.40%Sep 2020: 60.40%Dec 2020: 60.40%Mar 2021: 60.40%Jun 2021: 60.40%Sep 2021: 60.40%Dec 2021: 60.40%Mar 2022: 60.40%Jun 2022: 60.40%Sep 2022: 60.40%Dec 2022: 60.40%Mar 2023: 60.40%Jun 2023: 60.40%Sep 2023: 60.40%Dec 2023: 60.40%Mar 2024: 60.40%Jun 2024: 60.40%Sep 2024: 60.40%Dec 2024: 60.40%Mar 2025: 60.40%Jun 2025: 60.40%Sep 2025: 60.40%Dec 2025: 60.40%Mar 2026: 60.40%60.40%60.40%
Shareholding trend - last 6 quarters
Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Promoters60.40%60.40%60.40%60.40%60.40%60.40%
Public39.60%39.60%39.60%39.60%39.60%39.60%
Shareholding history - year on year (as at 31 March)
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019Mar 2018Mar 2017Mar 2016
Promoters60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%60.40%
Public39.60%39.60%39.60%39.60%39.60%39.60%39.60%39.60%39.60%39.60%39.60%
Promoter change (YoY, %pts)+0.00+0.00+0.00+0.00+0.00+0.00+0.00+0.00+0.00+0.00-

Board & Governance of Sanofi India Limited

As per the corporate governance filing with NSE for the quarter ended 31-MAR-2026, the board of Sanofi India Limited has 10 directors - 3 independent and 4 executive. The board is chaired by Aditya Narayan.

DirectorPositionOn board sinceListed boards
Aditya Narayan Non-Executive - Independent Director · Chairperson 2016-04-30 1
Usha Thorat Non-Executive - Independent Director 2016-04-30 1
Rahul Bhatnagar Non-Executive - Independent Director 2020-07-29 5
Sudipta Chakraborty Executive Director 2026-03-01 1
Vaibhav Karandikar Non-Executive - Non Independent Director 2023-12-01 1
Rachid Ayari Executive Director 2023-12-01 1
Eric Mansion Non-Executive - Non Independent Director 2024-06-03 1
Mahadev Gawade Executive Director 2025-08-11 1
Deepak Arora Executive Director · MD 2025-10-27 1
Rodolfo Hrosz Non-Executive - Non Independent Director 2025-05-01 1
Board Committees
CommitteeMembers
Audit Committee Rahul Bhatnagar (Chairperson), Usha Thorat, Vaibhav Karandikar
Nomination and remuneration committee Usha Thorat (Chairperson), Rahul Bhatnagar, Eric Mansion
Stakeholders Relationship Committee Usha Thorat (Chairperson), Deepak Arora, Rachid Ayari
Risk Management Committee Usha Thorat (Chairperson), Rahul Bhatnagar, Rachid Ayari, Mahadev Gawade, Deepak Arora
Corporate Social Responsibility Committee Usha Thorat (Chairperson), Rahul Bhatnagar, Deepak Arora

Group Structure of Sanofi India Limited

Sanofi India Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Sanofi India Limited's business expansion strategy and organizational complexity.

1
Subsidiary companies
Key Subsidiaries
Company Name CIN Shares Held
Sanofi Consumer Healthcare India Limited U21002MH2023PLC402652 -

Showing major subsidiaries. Total: 1.

Charges & Borrowings of Sanofi India Limited

Open charges
₹170.72 Cr
Satisfied charges
₹40.81 Cr
Breakdown by lending institutions
State Bank of India₹111.60 Cr
Icici Limited₹25.00 Cr
Hdfc Limited₹21.75 Cr
The First National City₹3.20 Cr
Unit Trust of India₹2.00 Cr
Others₹7.17 Cr
Latest charge details
DateLenderAmountStatus
20 Sep 2001 Hdfc Limited ₹19.75 Cr Open
25 Oct 1993 Icici Limited ₹5 Cr Open
31 Dec 1992 State Bank of India ₹40 Cr Open
03 Dec 1992 State Bank of India ₹40 Cr Open
11 Sep 1992 State Bank of India ₹3.2 Cr Open

Total charge records: 41 View all charges

Employees and EPFO Compliance at Sanofi India Limited

Sanofi India Limited has a workforce of 2,191 employees as of Jul 30, 2024.

Employee count
2,191
Active EPFO establishments
2
Employee growth
-8.13%
Premium access

Employee and EPFO history for Sanofi India Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Sanofi India Limited

Premium access

GST registrations and filing compliance for Sanofi India Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Sanofi India Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Sanofi India Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sanofi India Limited

Premium access

MSME payment history for Sanofi India Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sanofi India Limited

Premium access

Corporate group structure for Sanofi India Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sanofi India Limited

Premium access

MCA filings and documents for Sanofi India Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Sanofi India Limited

Activity
29 Apr 2026
Sanofi India Limited last Annual general meeting of members was held on 29 Apr 2026 as per latest MCA records.
Directors
01 Apr 2026
Siraj Azmat Chaudhry was appointed as a Director on 01 Apr 2026 & has been associated with this company since 4 months 24 days.
Directors
01 Apr 2026
Rajani Kesari was appointed as a Director on 01 Apr 2026 & has been associated with this company since 4 months 24 days.
Directors
01 Mar 2026
Sudipta Chakraborty was appointed as a Whole-Time Director on 01 Mar 2026 & has been associated with this company since 5 months 24 days.
Activity
31 Dec 2025
Sanofi India Limited has filed its annual Financial statements for the year ended 31 Dec 2025 with Roc Mumbai I.
Directors
29 Oct 2025
Haresh Bachubhai Vala was appointed as a Company Secretary on 29 Oct 2025 & has been associated with this company since 9 months 25 days.

Recent News on Sanofi India Limited

Frequently Asked Questions about Sanofi India Limited

Sanofi India Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 02 May 1956 (70+ years old) and is registered under CIN L24239MH1956PLC009794. Listed on BSE: 500674 and NSE: SANOFI. The company has 2,191 employees.

Sanofi India Limited reported revenue of ₹2,013.2 Cr for FY 2024 (down 29.39% YoY) based on consolidated NSE filings.

The current directors of Sanofi India Limited are:

The primary industry of Sanofi India Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Yes. Sanofi India Limited is listed on both BSE (code: 500674) and NSE (symbol: SANOFI).

Sanofi India Limited can be reached at the registered office: Sanofi House Cts No.117 – B L&T Business Park Saki Vihar Road Powai, Mumbai, Maharashtra, India – 400072, or through the website sanofiindialtd.com.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available